FGF/FGFR signaling in health and disease.
Xie Y, Su N, Yang J, Tan Q, Huang S, Jin M, Ni Z, Zhang B, Zhang D, Luo F, Chen H, Sun X, Feng JQ, Qi H, Chen L. · 2020
Read FGF/FGFR signaling in health and disease. by Xie Y, Su N, Yang J, Tan Q, Huang S, Jin M, Ni Z, Zhang B, Zhang D, Luo F, Chen H, Sun X, Feng JQ, Qi H, Chen L. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7468161.txt.
Introduction
Xie and co-authors review FGF and FGFR signaling in health and disease. This signal family guides embryo growth and adult tissue upkeep. It steers cell fate, growth, division, and death in many cell types.
The review covers the signal's roles in skeleton growth and repair. It adds lung, urinary system, muscle, and heart development and disease. Single factors such as FGF21 and FGF23 get their own focus. When signaling goes wrong, cancers and chronic kidney disease can follow. Drugs that boost or block these signals may help across many systems. The authors gather current knowledge into one map. It serves readers who track development, injury repair, and disease causes together.
Catalog record
| CREATOR | Xie Y, Su N, Yang J, Tan Q, Huang S, Jin M, Ni Z, Zhang B, Zhang D, Luo F, Chen H, Sun X, Feng JQ, Qi H, Chen L. |
|---|---|
| YEAR | 2020 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 302 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |